SPEA Olomouc, s. r. o.

What SPEA Olomouc, s. r. o. does

SPEA Olomouc, s. r. o. is a privately held Czech outpatient polyclinic ("poliklinika") headquartered in central Olomouc at nám. Národních hrdinů 769/2, founded in 1995 and operating since 1996. The facility delivers comprehensive ambulatory care across 23 specialist clinics, 4 general-practitioner offices for adults, 2 pediatric offices, and 3 dental offices, supported by radiodiagnostics (multidetector multispiral CT, fully digital X-ray, ultrasound), an accredited clinical biochemistry and hematology laboratory (OKBH; ČSN EN ISO 15189), infusion therapy, and an on-site pharmacy. Medical equipment is sourced from major international vendors including GE Healthcare, Olympus, and Cobas/Coulter/PATHFAST analyzers, with a 2024 EU-funded modernization of the gastroenterology department. The company operates two pharmacies (SPEA ground-floor with 6 dispensing points and Horní Lán with 2 dispensing points, opened May 2023) and a pharmacy e-shop (lekarnaspea.cz) with 15,000+ products and delivery via Zásilkovna, PPL, and Czech Post.

The business model combines public health insurance reimbursement (contracts with all Czech insurance companies) with self-pay services priced from the official List of Health Procedures (2025 maximum point value 1.58 Kč), corporate occupational health services under contracts with dozens of employers, and pharmacy retail (prescription, OTC, and a 2%-bonus loyalty card). Corporate GTM also routes through employee benefit voucher programs (Pluxee, Edenred, UP/Unišek, Benefit Plus). KARDI AI, a third-party AI-powered long-term ECG monitoring service (3–12 months) offered on a self-pay basis, is the only disclosed AI capability. The company is dually certified to ISO 9001:2015 and ISO 14001:2015 (since 2022), holds the ČEKIA Stability Award, and has MZ ČR educational accreditation. Management is led by jednatel (managing director) Mgr. Ilja Spurný and executive director Ing. Martin Pavlíček, MBA, with a stated total workforce of 134 (42 employed physicians, 6 rental physicians, plus healthcare workers and 13 operational staff). Operations remain single-region, serving Olomouc and surrounding area.

Name

SPEA Olomouc, s. r. o.

Legal name

SPEA Olomouc, s. r. o.

Website

https://spea.cz

Company type

Private

Founded year

1995

Operating status

Operating

Headcount range

101–250 employees

Short description

SPEA Olomouc is a privately held Czech outpatient polyclinic in Olomouc, founded 1995, operating 23 specialist clinics, primary care, dental, CT, X-ray, lab, and pharmacy services for the Olomouc regional population, billed primarily through Czech public health insurance plus self-pay, corporate occupational health, and pharmacy retail.

Ownership category

akta.pro rank

Headquarters

HQ city

Olomouc

HQ country

Czechia

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. Public Health Insurance Reimbursement: SPEA Olomouc has contractual relationships with all health insurance companies in the Czech Republic. Most medical services are reimbursed through the public health insurance system.
2. Self-Paying Patients (Samoplátci): Services not covered by public health insurance are paid directly by patients. The pricing follows the official List of Health Procedures with maximum point value of 1.58 Kč per point for 2025. Laboratory tests and various examinations are available for self-paying patients without a doctor's referral.
3. Occupational Health Services (B2B): Corporate clients (employers) pay for occupational health examinations and services required by labor law. SPEA serves dozens of contractual partner companies with diverse workplace risk factors.
4. Pharmacy Retail: The pharmacy serves patients who are not treated at SPEA as well as SPEA patients. Revenue from dispensing prescription and OTC medicines, health products, and cosmetics.
5. Customer Loyalty Card Program: Pharmacy customers earn 2% bonus on OTC goods purchases that can be redeemed for discounts on future purchases. Separate accounts per pharmacy location.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels5 records

Core offering

SPEA Olomouc, s. r. o. is a private polyclinic in Olomouc, Czech Republic, founded in 1995 and operational since 1996, providing comprehensive outpatient medical care through 23 specialty clinics, general practitioner offices for adults and children, dental offices, and diagnostic services including CT, X-ray, ultrasound, OCT, and a clinical laboratory. The company also operates two pharmacy locations and an online pharmacy (lekarnaspea.cz) with over 15,000 products, and delivers occupational health services to corporate clients.

Differentiator

Problem solved

Functional benefit

Products and services

• Primary Care Services
• Specialized Outpatient Clinics
• Radiodiagnostics (X-ray and Ultrasound)
• Computed Tomography (CT)
• OKBH Clinical Laboratory ISO 15189-accredited clinical laboratory providing biochemical, hematological, and immunological analyses using Cobas 6000, Coulter DXH900, and PATHFAST analyzers.
• Infusion Therapy
• Pharmacy Services (SPEA + Horní Lán + E-shop)
• Occupational Health Services
• Long-term ECG Monitoring (KARDI AI)

Quantifiable outcome

• CT scan results provided to patient on CD immediately after examination
• +3 more outcomes

Named customers1 record

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability2 records

Feature10 records

Partnerships

Four partnerships are on record, tiered core.

• Olympus Czech Group, s.r.o.coreTechnology or Integration · 1 January 2024Endoscopic equipment supplier for the gastroenterology department. EU-funded project 'SPEA Olomouc, s.r.o. – Modernizace vybavení pracoviště' (registration number CZ.318.0./0.0/0.0/24_118/0010703) financed by EU Recovery and Resilience Instrument via National Recovery Fund. Provided videoprocessor CV-1500, 3 videocolonoscopes CF-H 185L, monitor OEV 321UH, and cart. Goal is to increase availability of colorectal cancer prevention examinations.
• CompuGroup MedicalcoreTechnology or IntegrationInternational healthcare software company providing the PC Doctor ambulatory program used across the polyclinic's network version. This is the primary clinical information system for managing patient records and clinical workflows.
• COMPEK MEDICAL SERVICEScoreTechnology or IntegrationEquipment supplier for clinics and hospitals. Provided computer ECG systems, computer blood pressure and ECG Holters, fully equipped ergometry, and connected equipment to the PC Doctor network. Key vendor for cardiology diagnostic equipment.
• GE HealthCare (General Electric)coreTechnology or IntegrationSupplier of digital X-ray equipment, sonographs (ultrasound devices), and related diagnostic imaging equipment. Provided digital radiography and Logiq series ultrasound devices.

Scale indicators6 records

Recent moves8 records

Expansion highlights6 records

Broad incumbents

• Medicover: Medicover is a large private healthcare and diagnostics operator headquartered in Sweden with significant Central and Eastern European exposure (Poland, Romania, Germany, Czech Republic). It offers clinics, labs, and digital health at scale — overlapping SPEA's polyclinic + diagnostic lab model but across a much broader footprint and capital base.
• AGEL: AGEL is one of the largest private healthcare providers in the Czech Republic and Central Europe, operating hospitals, outpatient clinics, pharmacies, and labs. It competes with SPEA for the same insured patient base and physicians, though at much larger scale and with inpatient capabilities SPEA does not have.
• Penta Hospitals: Penta Hospitals is a Central European hospital and outpatient group (Slovakia, Czech Republic, Poland) backed by Penta Investments. It competes with SPEA in Czech outpatient specialties and would be a likely strategic acquirer or partner for any multi-site rollup of polyclinics like SPEA.

Direct peers

• EUC (European Health Centre): EUC operates the largest network of private outpatient clinics and hospitals in the Czech Republic, offering multi-specialty ambulatory care under similar contracts with Czech public health insurers. It is the closest scale peer to SPEA Olomouc's polyclinic model and competes directly for patients and physicians in regional Czech markets.
• Canadian Medical: Canadian Medical is a Czech private multi-specialty outpatient clinic chain offering GP, specialist, diagnostic, and preventive services across multiple Czech cities. It mirrors SPEA's full-service outpatient positioning under one roof and competes for the same insured and self-pay patient base.

Others

• Synlab: Synlab is Europe's largest medical diagnostics services provider, including clinical laboratory testing. It overlaps with SPEA's accredited OKBH biochemistry and hematology lab, particularly for external physician referrals, though Synlab is lab-specialized with no clinical care delivery.
• Pilulka: Pilulka is a leading Czech online pharmacy and health-product e-commerce platform. It competes directly with lekarnaspea.cz on online OTC and pharmacy retail, although Pilulka is pharmacy-only with no clinical services.
• Dr. Max (BENU): Dr. Max is the largest pharmacy retail chain in the Czech Republic (and broader CEE), with both physical stores and a major online platform. It is not a clinical peer but directly competes with SPEA's SPEA + Horní Lán pharmacies and lekarnaspea.cz e-shop on retail prescription and OTC volume.

Emerging players

• Asklepion: Asklepion is a Czech private healthcare group combining outpatient specialist clinics, day-surgery, and aesthetic/laser medicine in Prague. It overlaps with SPEA on multi-specialty outpatient delivery and Czech private-pay dynamics, but is concentrated in aesthetic and surgical niches rather than general polyclinic medicine.

Regional players

• Affidea: Affidea is a leading European provider of outpatient diagnostic imaging, cancer care, and specialty services across 15+ countries. It directly overlaps with SPEA's CT, X-ray, ultrasound, and laboratory diagnostics, though Affidea is imaging-specialized rather than full multi-specialty primary care.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Facebookfacebook.com/SPEAOlomoucpoliklinika
• LinkedInlinkedin.com/company/thuiszorg-comfort-bv

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SPEA Olomouc, s. r. o.